Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis-Reference-Cited by-同舟云学术

Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis

Published:2013-08-30 Issue:10 Volume:4 Page:942-947
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Deng Hongfeng¹,Bernier Sylvie G.¹,Doyle Elisabeth¹,Lorusso Jeanine¹,Morgan Barry A.¹,Westlin William F.¹,Evindar Ghotas¹

Affiliation:

1. Department of Medicinal Chemistry and ‡Department of Preclinical Research, Praecis Pharmaceuticals Incorporated, 830 Winter Street, Waltham, Massachusetts 02451, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml400194r

Reference19 articles.

1. Multiple sclerosis

2. Multiple sclerosis

3. Amelioration of Experimental Autoimmune Encephalomyelitis in Lewis Rats by FTY720 Treatment

4. Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. O- and N-Heterocycles Synthesis;Lawesson’s Reagent in Heterocycle Synthesis;2021-09-11

2. DNA‐Encoded Libraries: Hydrazide as a Pluripotent Precursor for On‐DNA Synthesis of Various Azole Derivatives;Chemistry – A European Journal;2021-04-27

3. Tailor‐Made Amino Acids and Fluorinated Motifs as Prominent Traits in Modern Pharmaceuticals;Chemistry – A European Journal;2020-07-09

4. The ceramide-S1P pathway as a druggable target to alleviate peripheral neuropathic pain;Expert Opinion on Therapeutic Targets;2020-07-09

5. Design and synthesis of selective sphingosine-1-phosphate receptor 1 agonists with increased phosphorylation rates;Acta Pharmaceutica Sinica B;2020-06